Cargando…
Pharmacodynamic testing and new validated HPLC method to assess the interchangeability between multi-source orlistat capsules
BACKGROUND: Orlistat is an irreversible inhibitor of the lipase enzyme that prevents trigylcerides from being digested, thereby inhibiting triglyceride hydrolysis and absorption. The resultant reduced calorie uptake enables a positive effect on weight control. Systemic absorption of the drug is, the...
Autores principales: | Zaid, Abdel Naser, Zohud, Nihal, E’layan, Bushra, Aburadi, Tasneem, Jaradat, Nidal, Ali, Iyad, Hussein, Fatima, Ghanem, Mashhour, Qaddomi, Aiman, Abu Zaaror, Yara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701567/ https://www.ncbi.nlm.nih.gov/pubmed/29200824 http://dx.doi.org/10.2147/DDDT.S138926 |
Ejemplares similares
-
Stability of extemporaneously prepared sitagliptin phosphate solution
por: Zaid, Abdel Naser, et al.
Publicado: (2022) -
Anti-Lipase Potential of the Organic and Aqueous Extracts of Ten Traditional Edible and Medicinal Plants in Palestine; a Comparison Study with Orlistat
por: Jaradat, Nidal, et al.
Publicado: (2017) -
RP-HPLC Method Development and Validation of Synthesized Codrug in Combination with Indomethacin, Paracetamol, and Famotidine
por: Assali, Mohyeddin, et al.
Publicado: (2020) -
Identification of substandard drug products using electronic tongue: cefdinir suspension as a pilot example
por: Abu-Khalaf, Nawaf, et al.
Publicado: (2019) -
Brand and generic medications: Are they interchangeable?
por: Al-Jazairi, Abdulrazaq S., et al.
Publicado: (2008)